WallStreetZenWallStreetZen

How to Buy Monte Rosa Therapeutics Stock

Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics, Inc. , a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins.

Monte Rosa Therapeutics stock last closed at $6.25, up 5.04% from the previous day, and has increased 3.48% in one year. It has overperformed other stocks in the Biotechnology industry by 0.09 percentage points. Monte Rosa Therapeutics stock is currently +156.15% from its 52-week low of $2.44, and -29.3% from its 52-week high of $8.84.

As of Sep 19, 2024, there are 61.37M shares of GLUE outstanding. The market value of GLUE is $383.58M. In the last 24 hours, 211,269 GLUE shares were traded.

How to Buy Monte Rosa Therapeutics Stock

Wondering how to invest in Monte Rosa Therapeutics stock? Here's how.
  1. Figure out where to buy Monte Rosa Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you figure out where to buy Monte Rosa Therapeutics stock.
  2. Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
  3. Fund your brokerage account: Select your payment method and add your info.
  4. Research Monte Rosa Therapeutics stock: The Monte Rosa Therapeutics ticker symbol is GLUE. Is Monte Rosa Therapeutics stock a good investment? Should you buy shares of GLUE? How do GLUE's underlying business fundamentals look? Do top analysts think Monte Rosa Therapeutics is a good buy? Why has GLUE's stock price moved recently? (Hint: Our stock research tools can help you decide if GLUE is a good stock to buy).
  5. Execute your GLUE purchase: Decide if you will purchase GLUE shares at the current market price or use a limit order to purchase GLUE stock at a given price.
  6. Keep tabs on your GLUE investment: Create a watchlist to the latest updates on your new investment in Monte Rosa Therapeutics stock.

Step 1: Figure out where to buy Monte Rosa Therapeutics stock

You will need a brokerage account in order to access the NASDAQ market and buy GLUE stock.

A brokerage account allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our research, eToro is the best stock brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to global financial markets: From Technology to Energy, New York to Shanghai — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your share purchase by opening an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've picked your brokerage, it's time to fill out some personal details so you can invest in GLUE today.

How to Start a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to create a new brokerage account.
  1. Submit your information by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you have finished signing up on one of the best stock market apps, you need to deposit funds:

Check out the tutorial below to see the process of depositing money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Monte Rosa Therapeutics stock

Once you have selected the best place to buy Monte Rosa Therapeutics stock, it's crucial to evaluate their stock prior to buying, so you actually wrap your head around the risk and upside.

Monte Rosa Therapeutics stock at a glance

GLUE Price
$6.25
1w %
4.87%
1y %
3.48%
5y %
N/A
P/E
-2.8x
P/B
1.71x
P/S
77.16x
PEG
N/A
Revenue
$5.76M
Earnings
-$130.41M
Fore. Rev. Growth
62.56%
Fore. Earn. Growth
N/A
Market Cap
$383.58M
Next Earnings
N/A
Next Dividend
N/A

Monte Rosa Therapeutics Due Diligence Checks

WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis.

You can view all of the due diligence checks on GLUE's stock page.

What is the fair value of GLUE stock?

Investors use many financial metrics, analyses, models, and charts to gauge GLUE's intrinsic value.

Using relative valuations measures:

  • GLUE may be undervalued based on its P/B ratio of 1.71x, relative to Biotechnology industry P/B ratio of 6.51x

You can do more valuation research on GLUE's stock here.

GLUE Financial Summary

Signs that GLUE is financially healthy:

  • GLUE has $267.07M in cash and short term investments. This is sufficient to cover its annual cash burn of $67.76M.
  • GLUE has cash burn of 67758000. It has enough cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than long-term liabilities on the GLUE balance sheet.
  • There are more short-term assets than short-term liabilities on the GLUE balance sheet.

Signs that GLUE is not financially healthy:

  • GLUE profit margin has gone down from N/A to -2,264.5% in the past year.
  • GLUE has a relatively high debt to equity ratio of 0.53.

Do Wall Street analysts think it's a good time to buy GLUE stock

Out of 3 Wall Street analysts who give forecasts on GLUE, the consensus analyst rating on Monte Rosa Therapeutics is a Strong Buy

It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.

You can dive deeper into what analysts are forecasting on the Monte Rosa Therapeutics stock forecast page.

GLUE Trading Indicators

SMA10
6
SMA20
6.1
SMA50
5.14
SMA100
4.75
SMA200
5.29
MACD
0.24
MACD Signal
0.31
MACD Histogram
-0.07
RSI
56.76
Stochastic %K
43.1
Stochastic %D
31.73
StochRSI %K
44.22
StochRSI %D
26.03

Are GLUE insiders buying or selling the stock?

In the last 12 months, insiders at GLUE have sold more shares than they have bought.

Versant Venture Capital Vi LP, 10% Owner of GLUE, was the latest GLUE insider to sell. They sold $57,097.04 worth of GLUE shares on Sep 13, 2024.

Get more info about who owns GLUE shares here.

Can I rely on GLUE as an income stream?

No, Monte Rosa Therapeutics doesn't provide an income stream by paying out dividends.

GLUE Social Trading Data

One of the primary reasons eToro is our favorite brokerage is because of its social trading community.

Click below to learn what other traders have to say.

Step 5: Execute your GLUE purchase

You have two main order types:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are usually the best for newer investors.
  • Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
    If you want to ensure you're buying or selling at a specific dollar amount limit, place a limit order.

Click the Open Trade button and eToro will execute the order.

If you require additional info about investing in stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Keep tabs on your GLUE investment

Now that you own some shares in GLUE, you'll want to stay up-to-date on your shares.

Start a watchlist to see the latest developments about your GLUE stock.

GLUE Feed

How to Buy Stock in Monte Rosa Therapeutics

To summarize, here are the 6 steps for buying Monte Rosa Therapeutics stock:

  1. Figure out where to buy Monte Rosa Therapeutics stock
  2. Open your brokerage account
  3. Fund your brokerage account
  4. Research Monte Rosa Therapeutics stock
  5. Execute your GLUE purchase
  6. Keep tabs on your GLUE investment

If you are looking for a place to buy stocks, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to keep track of your investment in Monte Rosa Therapeutics, click below.

NASDAQ: GLUE
$6.25+0.30 (+5.04%)
Updated Sep 19, 2024
Open eToro Account
NASDAQ: GLUE
$6.25+0.30 (+5.04%)
Updated Sep 19, 2024
Open eToro Account

FAQ

How much does it cost to buy one Monte Rosa Therapeutics share?

As of Sep 19, 2024, it costs $6.25 to buy one share of Monte Rosa Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.48 shares of GLUE.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Monte Rosa Therapeutics stock?

According to 3 Wall Street analysts who monitor Monte Rosa Therapeutics, their consensus recommendation is to buy Monte Rosa Therapeutics stock.

What is the best way to buy Monte Rosa Therapeutics stock?

One way to place an order for Monte Rosa Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.